Cite
APA Citation
Borenäs, M., Umapathy, G., Lai, W., Lind, D. E., Witek, B., Guan, J., Mendoza‐Garcia, P., Masudi, T., Claeys, A., Chuang, T., El Wakil, A., Arefin, B., Fransson, S., Koster, J., Johansson, M., Gaarder, J., Van den Eynden, J., Hallberg, B., & Palmer, R. H. (2021). aLK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation. EMBO journal, 40, n/a. http://access.bl.uk/ark:/81055/vdc_100120453653.0x000052